Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Cardiovascular4053 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A15115 | 29087391 | Am J Gastroenterol | Prognostic Value of Controlled Attenuation Parameter by Transient Elastography. | 2017 | Details |
A15118 | 29085919 | Hepatol Commun | MELD-Na score predicts incident major cardiovascular events, in patients with nonalcoholic fatty liver disease (NAFLD). | 2017 | Details |
A15122 | 29085222 | World J Gastroenterol | Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. | 2017 | Details |
A15123 | 29085206 | World J Gastroenterol | Nonalcoholic fatty liver disease: Evolving paradigms. | 2017 | Details |
A15131 | 29083036 | Aliment Pharmacol Ther | Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease. | 2017 | Details |
A15136 | 29080046 | Curr Gastroenterol Rep | The Microbiome That Shapes Us: Can It Cause Obesity? | 2017 | Details |
A15160 | 29067086 | Pak J Med Sci | The effect of omega-3 unsaturated fatty acids on non-alcoholic fatty liver disease: A systematic review and meta-analysis of RCTs. | 2020 | Details |
A15174 | 29063908 | Am J Gastroenterol | Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance. | 2017 | Details |
A15185 | 29058029 | Eur Radiol | Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study. | 2017 | Details |
A15210 | 29046007 | Dtsch Med Wochenschr | [Dietary Recommendations in Metabolic Vascular Syndrome]. | 2017 | Details |
A15213 | 29043609 | Curr HIV/AIDS Rep | The Fat of the Matter: Obesity and Visceral Adiposity in Treated HIV Infection. | 2017 | Details |
A15237 | 29028831 | PLoS One | Short-term vitamin E treatment impairs reactive oxygen species signaling required for adipose tissue expansion, resulting in fatty liver and insulin resistance in obese mice. | 2017 | Details |
A15248 | 29024702 | Metabolism | Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. | 2017 | Details |
A15265 | 28994882 | Tunis Med | Cardiovascular risk estimation in non alcoholic fatty liver disease. | 2016 | Details |
A15271 | 28993031 | Trends Mol Med | Targeting ATP-Citrate Lyase in Hyperlipidemia and Metabolic Disorders. | 2017 | Details |
A15276 | 28989978 | NPJ Precis Oncol | The therapeutic potential of resveratrol: a review of clinical trials. | 2017 | Details |
A15290 | 28985395 | ILAR J | Nonhuman Primates and Translational Research-Cardiovascular Disease. | 2017 | Details |
A15308 | 28972487 | Georgian Med News | EFFECT THE CARDIOMETABOLIC RISK FACTORS ON VASCULAR AGING IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE CONCOMITANT WITH SUBCLINICAL HYPOTHYROIDISM. | 2017 | Details |
A15333 | 28964324 | Metabolism | Coffee consumption is not associated with prevalent subclinical cardiovascular disease (CVD) or the risk of CVD events, in nonalcoholic fatty liver disease: results from the multi-ethnic study of atherosclerosis. | 2017 | Details |
A15338 | 28960360 | Aliment Pharmacol Ther | Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non-alcoholic fatty liver disease. | 2017 | Details |
A15345 | 28955037 | Sci Rep | Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis. | 2017 | Details |
A15346 | 28954437 | Nutrients | Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals. | 2017 | Details |
A15373 | 28941364 | Hepatology | Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study. | 2018 | Details |
A15383 | 28936403 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications. | 2017 | Details |
A15388 | 28935188 | Dig Liver Dis | Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity. | 2017 | Details |
A15402 | 28929125 | Open Forum Infect Dis | The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus. | 2017 | Details |
A15420 | 28922438 | J Gastrointestin Liver Dis | Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study. | 2017 | Details |
A15422 | 28921469 | Adv Exp Med Biol | Microbial Factors in Inflammatory Diseases and Cancers. | 2017 | Details |
A15429 | 28918389 | J Investig Med | Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option. | 2017 | Details |
A15435 | 28914096 | Exp Biol Med (Maywood) | MicroRNAs as biomarkers for clinical studies. | 2017 | Details |
A15466 | 28894050 | Postepy Hig Med Dosw (Online) | Compounds of psoriasis with obesity and overweight. | 2017 | Details |
A15467 | 28892924 | J Clin Diagn Res | Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats. | 2017 | Details |
A15480 | 28883393 | Nat Commun | Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function. | 2017 | Details |
A15508 | 28869506 | Int J Mol Sci | Critical Role of the Human ATP-Binding Cassette G1 Transporter in Cardiometabolic Diseases. | 2017 | Details |
A15511 | 28868179 | World J Gastrointest Pathophysiol | Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients. | 2017 | Details |
A15548 | 28848168 | Horm Res Paediatr | Novel Insights in the Metabolic Syndrome in Childhood and Adolescence. | 2017 | Details |
A15615 | 28809727 | Ann Hepatol | Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine. | 2018 | Details |
A15626 | 28802566 | Gastroenterology | Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease. | 2017 | Details |
A15685 | 28760353 | Clin Res Hepatol Gastroenterol | Evaluation of endothelial dysfunction in patients with nonalcoholic fatty liver disease: Association of selenoprotein P with carotid intima-media thickness and endothelium-dependent vasodilation. | 2017 | Details |
A15714 | 28748119 | J Adv Res | Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review. | 2016 | Details |
A15730 | 28740627 | J Cardiovasc Thorac Res | Correlation between severity of ultrasonographic nonalcoholic fatty liver disease and cardiometabolic risk among Filipino wellness patients. | 2017 | Details |
A15763 | 28722453 | Cas Lek Cesk | [Psoriasis comorbidities]. | 2019 | Details |
A15767 | 28720429 | Pharmacol Ther | Stable isotope-based flux studies in nonalcoholic fatty liver disease. | 2017 | Details |
A15784 | 28710554 | Obes Surg | Morphofunctional Changes After Sleeve Gastrectomy and Very Low Calorie Diet in an Animal Model of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
A15797 | 28705466 | Clin Nutr | Serum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adults. | 2017 | Details |
A15804 | 30568543 | J Med Biochem | Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease. | 2017 | Details |
A15808 | 28699503 | Curr Med Chem | Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach. | 2017 | Details |
A15834 | 28689596 | Clin Liver Dis | Extrahepatic Manifestations of Hepatitis C Virus After Liver Transplantation. | 2017 | Details |
A15843 | 28686220 | Children (Basel) | The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children. | 2017 | Details |
A15845 | 28685623 | Expert Opin Pharmacother | Cardiovascular disease prevention strategies for type 2 diabetes mellitus. | 2017 | Details |
A15862 | 28677333 | Aliment Pharmacol Ther | Review article: new treatments in non-alcoholic fatty liver disease. | 2017 | Details |
A15868 | 28676747 | Front Hum Neurosci | Inflammation: The Common Pathway of Stress-Related Diseases. | 2017 | Details |
A15870 | 28676332 | Respir Physiol Neurobiol | Circulating exosomes in obstructive sleep apnea as phenotypic biomarkers and mechanistic messengers of end-organ morbidity. | 2017 | Details |
A15871 | 28676027 | Curr Vasc Pharmacol | The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options? | 2018 | Details |
A15872 | 28676026 | Curr Vasc Pharmacol | A Critical Approach of Guideline Therapeutic Recommendations for NAFLD. | 2018 | Details |
A15873 | 28676025 | Curr Vasc Pharmacol | Nonalcoholic Fatty Liver Disease vs. Nonalcoholic Steatohepatitis: Pathological and Clinical Implications. | 2018 | Details |
A15874 | 28676024 | Curr Vasc Pharmacol | NAFLD-NASH: An Under-Recognized Epidemic. | 2018 | Details |
A15876 | 28676019 | Curr Vasc Pharmacol | Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk. | 2018 | Details |
A15877 | 28676018 | Curr Vasc Pharmacol | Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease? | 2018 | Details |
A15884 | 28673574 | Med Hypotheses | LDL-C levels in older people: Cholesterol homeostasis and the free radical theory of ageing converge. | 2017 | Details |
A15889 | 28669329 | Curr Vasc Pharmacol | Effect of Low (5 mg) vs. High (20-40 mg) Rosuvastatin Dose on 24h Arterial Stiffness, Central Haemodynamics, and Non-Alcoholic Fatty Liver Disease in Patients with Optimally Controlled Arterial Hypertension. | 2018 | Details |
A15890 | 28669328 | Curr Vasc Pharmacol | Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome? | 2018 | Details |
A15902 | 28660151 | J Clin Transl Hepatol | Nonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis. | 2017 | Details |
A15917 | 28652891 | World J Hepatol | Non-alcoholic fatty liver disease: An expanded review. | 2017 | Details |
A15929 | 28647324 | Trends Endocrinol Metab | AMPK as a Therapeutic Target for Treating Metabolic Diseases. | 2017 | Details |
A15944 | 28641782 | Metabolism | High prevalence of apolipoprotein B dyslipoproteinemias in non-alcoholic fatty liver disease: The lifelines cohort study. | 2017 | Details |
A15945 | 28641570 | Endocr Metab Immune Disord Drug Targets | 1h Post-load Blood Glucose in the Identification of Proatherogenic Cardiometabolic Profile in Obesity. | 2017 | Details |
A15947 | 28640662 | Gut Microbes | Using probiotics in clinical practice: Where are we now? A review of existing meta-analyses. | 2017 | Details |
A15951 | 28639757 | Rev Med Suisse | [Ketogenic diets : the miraculous solution ?] | 2017 | Details |
A15960 | 28637103 | Korean J Gastroenterol | [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
A15962 | 28637101 | Korean J Gastroenterol | [Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
A15966 | 28635324 | Antioxid Redox Signal | Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis. | 2017 | Details |
A15972 | 28632197 | Nutrients | Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD. | 2017 | Details |
A15975 | 28630692 | J Nutr Sci | Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop. | 2017 | Details |
A15992 | 28622441 | Transpl Int | Cardiovascular mortality among liver transplant recipients with nonalcoholic steatohepatitis in the United States-a retrospective study. | 2017 | Details |
A16002 | 28618991 | Curr Med Chem | Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions. | 2018 | Details |
A16007 | 28613087 | Expert Rev Gastroenterol Hepatol | An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia. | 2017 | Details |
A16021 | 28606575 | Nutrition | Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study. | 2017 | Details |
A16022 | 28606220 | Nutr Res Rev | Current and future strategies for the nutritional management of cardiometabolic complications of androgen deprivation therapy for prostate cancer. | 2017 | Details |
A16033 | 28599248 | Biomed Pharmacother | The multifaceted role of natriuretic peptides in metabolic syndrome. | 2017 | Details |
A16036 | 28598410 | Children (Basel) | Pediatric Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
A16039 | 28596817 | World J Hepatol | Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do. | 2017 | Details |
A16045 | 28595552 | Curr Med Chem | Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications. | 2018 | Details |
A16076 | 28581362 | Future Cardiol | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ. | 2017 | Details |
A16077 | 28581332 | Future Cardiol | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α. | 2017 | Details |
A16081 | 28579536 | Gastroenterology | Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. | 2017 | Details |
A16082 | 28579247 | J Clin Lipidol | Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome. | 2017 | Details |
A16090 | 28577233 | Biol Trace Elem Res | Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet. | 2017 | Details |
A16092 | 28575232 | J Clin Endocrinol Metab | Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial. | 2017 | Details |
A16096 | 28573067 | World J Gastrointest Pathophysiol | Non-alcoholic fatty liver disease and cardiovascular risk. | 2017 | Details |
A16107 | 28566439 | Eur J Endocrinol | MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. | 2017 | Details |
A16120 | 28554682 | Clin Gastroenterol Hepatol | Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. | 2017 | Details |
A16126 | 28550272 | J Biomed Res | Non-alcoholic fatty liver disease--a chronic disease of the 21<sup>st</sup> century. | 2018 | Details |
A16132 | 28545937 | J Hepatol | Treatment of NAFLD with diet, physical activity and exercise. | 2017 | Details |
A16141 | 28542544 | PLoS One | Development and characterization of an experimental model of diet-induced metabolic syndrome in rabbit. | 2017 | Details |
A16142 | 28542113 | Eur J Gastroenterol Hepatol | Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2017 | Details |
A16145 | 28539915 | Front Microbiol | The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease. | 2017 | Details |
A16154 | 28534852 | Nutrients | Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies. | 2017 | Details |
A16157 | 28533672 | World J Gastroenterol | Effect of a counseling-supported treatment with the Mediterranean diet and physical activity on the severity of the non-alcoholic fatty liver disease. | 2017 | Details |
A16164 | 28529199 | J Clin Res Pediatr Endocrinol | Can Fetuin-A Be a Marker for Insulin Resistance and Poor Glycemic Control in Children with Type 1 Diabetes Mellitus? | 2017 | Details |